Souhaitez-vous accéder aux communiqués récents ?

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Variations to Marketing Authorisations (June 2nd - June 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. This course...

- Veteran biopharmaceutical and oncology leader brings more than three decades of experience across clinical development, regulatory, and operational execution SOUTH SAN FRANCISCO, Calif., April 13,...

Veld Pharmaceuticals, announced a collaboration with Chiesi Farmaceutici S.p.A in Africa for Rare Disease Therapies

Israel Tech Week 2026 moves forward in Miami, connecting Israeli startups, investors and global partners amid ongoing conflict in Israel.

Financing secures path to first NDA submission for buntanetap6-Month symptomatic data readout anticipated Q1 2027Alzheimer’s disease Phase 3 trial 75% enrolledParkinson's disease open-label study 28%...

Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The "US FDA - Understanding Key Factors When Working with the FDA (May 12, 2026)" training has been added to ResearchAndMarkets.com's offering.This course...

Israel Tech Week 2026 moves forward in Miami, connecting Israeli startups, investors and global partners amid ongoing conflict in Israel.

SAN DIEGO, April 09, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced...

Austin, TX, USA, April 09, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Centrifugal High-Speed Separators Market Size, Trends and Insights By Type...

VANCOUVER, British Columbia, April 08, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary — Biotechs that went public in Q1 2026 raised a median of $287.5 million each; and nearly every one...